Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
FDA Grants Orphan Drug Designation to Cevidoplenib for ITP 2024-03-21 20:00
Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease 2024-02-23 21:00
Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease 2023-09-14 20:00
Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib 2023-02-24 22:00
1